immunology

Sanofi
Biotech

Sanofi pens $1.8B deal for 2 autoimmune, immunology bispecifics

Sanofi continues to splash the cash for autoimmune and immunology assets this spring, including a deal with Earendil Labs stretching to $1.8 billion.
James Waldron Apr 17, 2025 8:51am
Photo of a final puzzle piece about to fit into a puzzle

Sanofi hands over $600M upfront for Dren Bio's bispecific

Mar 20, 2025 5:58am
bumpy road rough bad path

Merck KGaA fails lupus trial arm, plans further development

Mar 6, 2025 7:25am
Three blocks displaying from left to right a person a handshake and another person

Takeda fronts $46M for 2nd small molecule collab with BridGene

Feb 25, 2025 8:00am
red and purple piggy banks

Boston biotech banks $90M for next-gen bispecifics

Feb 14, 2025 10:10am
pipelines in the sun

Lilly's next focus: Testing incretins in neuro, immunology fields

Feb 6, 2025 2:35pm